Illness	Number of cases
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	194
Cystitis (N30.0)	98
Hyperplasia of prostate (N40)	31
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	29
Malignant neoplasm of prostate (C61)	28
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1)	28
Acute tubulo-interstitial nephritis (N10)	20
Cystitis (N30.2)	20
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by renal calculi (N13.20)	19
Orchitis and epididymitis (N45.9)	19

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	640
Insertion, exchange or removal of a ureteral stent (8-137.x)	207
Examination of the urethra and the urinary bladder by endoscopy (1-661)	185
Insertion, exchange or removal of a ureteral stent (8-137.00)	177
Computed tomography (CT) of the abdomen without contrast medium (3-207)	172
Surgical incision into the ureter or removal of a stone during an open operation or endoscopy (5-562.8)	139
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	126
Insertion, exchange or removal of a ureteral stent (8-137.10)	116
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	105
(5-98k.1)	105

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
66	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
48	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
41	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Doctoral supervision
Editors of scientific journals/textbooks